FilingReader Intelligence
Zhejiang Garden Bio-Chemical reallocates 99m yuan in strategy shift
August 15, 2025 at 05:34 PM UTC•By FilingReader AI
Zhejiang Garden Bio-Chemical reallocated 99 million yuan from its generic drug R&D project to a new solid and injectable preparations project, reflecting a strategic shift toward higher-value products.
The company has extended completion dates for several projects including vitamin A/E powder, vitamin B6, biotin, and L-alanine due to market conditions and technological optimization.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SZSE:300401•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Zhejiang Garden Bio-Chemical High-tech publishes news
Free account required • Unsubscribe anytime